An experimental therapy aims to maximize muscle mass by blocking the pathways that restrict muscle growth. Which of the following statements correctly describes how myostatin causes muscle breakdown, and the physiological effect of blocking these pathways?

Question

Accepted Answer

Myostatin signalling activates Smad2/3, which inhibits the Akt pathway to allow FOXO3a-induced protein degradation; consequently, blocking both Myostatin and Activin B together yields a synergistic 156% increase in muscle mass.

✅

Answer

IGF-1 signalling activates Smad2/3 to degrade muscle; consequently, blocking Myostatin and Activin A in combination yields only an 18% increase in muscle mass.

Answer

Myostatin signalling inhibits ActRIIA/IIB and ALK4 receptors to prevent muscle degradation; consequently, blocking both Activin B and Myostatin leads to severe muscle wasting and a 156% decrease in mass.

❌

Answer

Myostatin signalling activates Akt to directly turn on protein synthesis; consequently, blocking Myostatin alone is the most effective therapy, yielding a 117% increase in muscle mass.

Crowdly

An experimental therapy aims to maximize muscle mass by blocking the pathways th...

Хочете миттєвий доступ до всіх перевірених відповідей на learning.monash.edu?